News - NECC Criminal Trial Continues
The federal criminal trial against Barry Cadden continues in Boston and will be entering its fitth week. Cadden was an owner and pharmacist acting as the chief operating role at the New England Compounding Center in Framingham, Massachusetts. Federal prosecutors allege more than 60 people from at least seven states died after receiving a fungus-contaminated deadly drug prepared by NECC. More than 2000 were sickened in the nationwide outbreak of fungal meningitis that followed, including persons in Indiana and southern Michigan, many of whom are represented by Foley & Small.
Updates on the trial can by found on the Blog by Walter F. Roche Jr. - meningitis - etc. It can by found at http://meningitis-etc.blogspot.com/
St. Jude Medical Defibrillator Recall
FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
NECC Second Payments Expected This Summer
Tort Trustee Reports Payment Expectation at MDL Status Conference
Final NECC Victims' MDL Payments Due By Summer
The second and final payments to victims of the 2012 fungal meningitis outbreak should come this summer and the underlying court case should be nearing final resolution by August.
Cadden Guilty in NECC Criminal Trial
NECC owner Barry Cadden guilty on racketeering and fraud claims
What is Mass Tort Litigation?
Often seen with defective drugs or medical implants.